Howe & Rusling Inc Cytokinetics Inc Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$11.15 - $24.64 $3,122 - $6,899	-280 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$8.75 - $16.3 $936 - $1,744	107 Added 61.85%	280 $3,000
Q2 2019 Aug 12, 2019	SELL	$7.95 - $11.25 $119 - $168	-15 Reduced 7.98%	173 $2,000
Q1 2019 Apr 29, 2019	SELL	$5.95 - $10.19 $178 - $305	-30 Reduced 13.76%	188 $2,000
Q4 2018 Feb 04, 2019	BUY	$5.91 - $9.29 $413 - $650	70 Added 47.3%	218 $1,000
Q1 2018 May 14, 2018	SELL	$7.2 - $10.05 $136 - $190	-19 Reduced 11.38%	148 $1,000
Q3 2017 Oct 18, 2017	BUY	$12.0 - $15.0 $2,004 - $2,505	167	167 $2,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.88B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.